BCI Minerals Limited (BIRNF)
USD 0.17
(0.0%)
USD 0.17
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -27.07 Million | -1.27 Million | 27.33 Million | 6.92 Million | 3.01 Million | -4.31 Million |
| Net Income | -15.32 Million | 6.24 Million | -10.68 Million | 16.49 Million | 259.56 Thousand | 9.43 Million |
| Depreciation & Amortization | 7.26 Million | 5.04 Million | 5.68 Million | 3.73 Million | 2.16 Million | 1.84 Million |
| Deferred income taxes | - | -697 Thousand | -951 Thousand | -703.11 Thousand | -127.99 Thousand | -117.98 Thousand |
| Stock-based compensation | 933 Thousand | 697 Thousand | 951 Thousand | 703.11 Thousand | 127.99 Thousand | 117.98 Thousand |
| Change in working capital | -42.63 Million | -2 Million | 34.82 Million | -15.53 Million | 4.03 Million | -4.06 Million |
| Other non-cash items | 22.68 Million | -10.55 Million | -2.49 Million | 2.23 Million | -3.44 Million | -11.52 Million |
| Investing Cash Flow | -212.34 Million | -146.45 Million | -98.45 Million | -12.67 Million | 2.38 Million | 18.8 Million |
| Investments in PPE | -216.02 Million | -152.9 Million | -98.47 Million | -12.77 Million | -4.93 Million | -110.17 Thousand |
| Acquisitions | - | 2664.00 | 24.84 Thousand | 225.97 Thousand | - | 701.75 |
| Investment purchases | 3.64 Million | -9.68 Million | - | -124.62 Thousand | -130.12 Thousand | -238.59 Thousand |
| Sales/Maturities of investments | 38 Thousand | 6.44 Million | - | - | - | -340 Thousand |
| Other Investing Activities | 3.67 Million | 9.68 Million | 1.00 | 1.00 | 7.44 Million | 19.49 Million |
| Financing Cash Flow | 388.86 Million | 66.1 Million | 176.4 Million | 34.19 Million | - | - |
| Debt repayment | -85 Million | -66.6 Million | -498 Thousand | -327 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -121.21 Thousand | - | - | - | - |
| Common Stock Issuance | 304.47 Million | - | 176.75 Million | 34.43 Million | - | - |
| Other Financing Activities | -605 Thousand | 132.83 Million | -343.63 Thousand | -245.49 Thousand | - | - |
| Accounts receivables | -9.48 Million | 7.25 Million | 12.25 Million | -32.88 Million | 3.99 Million | -10.11 Million |
| Accounts payables | - | -9.63 Million | 19.83 Million | 16.98 Million | -180.38 Thousand | 6.11 Million |
| Inventory | - | - | 1.00 | 1.00 | - | - |
| Other working capital | -33.14 Million | 378.95 Thousand | 2.74 Million | 358.85 Thousand | 220.32 Thousand | -64.56 Thousand |
| Cash at beginning of period | 109.47 Million | 160.09 Million | 59.63 Million | 28.6 Million | 23.65 Million | 9.64 Million |
| Cash at end of period | 258.91 Million | 72.9 Million | 160.09 Million | 59.63 Million | 28.6 Million | 23.65 Million |
| Capital Expenditure | -216.02 Million | -152.9 Million | -98.47 Million | -12.77 Million | -4.93 Million | -110.17 Thousand |
| Effect of forex changes on cash | - | -5.57 Million | -4.82 Million | 2.58 Million | - | - |
| Net cash flow / Change in cash | 149.44 Million | -87.19 Million | 100.46 Million | 31.03 Million | 4.95 Million | 14 Million |
| Free Cash Flow | -243.09 Million | -154.17 Million | -71.14 Million | -5.84 Million | -1.91 Million | -4.42 Million |
| Breakdown | 2024 FY | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | -505.13 Thousand | 4.1 Million | 6.24 Million | 2.18 Million | -10.68 Million |
| Depreciation & Amortization | - | 2.82 Million | 2.35 Million | 5.04 Million | 2.29 Million | 5.68 Million |
| Deferred income taxes | - | - | - | -697 Thousand | - | -951 Thousand |
| Stock-based compensation | - | - | - | 697 Thousand | - | 951 Thousand |
| Change in working capital | - | - | - | -2 Million | - | 34.82 Million |
| Other non-cash items | - | -3.04 Million | -7.58 Million | -10.55 Million | 4.77 Million | -2.49 Million |
| Investing Cash Flow | -212.34 Million | -58.03 Million | -55.22 Million | -146.45 Million | -93.33 Million | -98.45 Million |
| Investments in PPE | -216.02 Million | -58.03 Million | -61.44 Million | -152.9 Million | -93.56 Million | -98.47 Million |
| Acquisitions | - | - | - | 2664.00 | 2725.56 | 24.84 Thousand |
| Investment purchases | 3.64 Million | - | - | -9.68 Million | - | - |
| Sales/Maturities of investments | 38 Thousand | - | 6.21 Million | 6.44 Million | 231.67 Thousand | - |
| Other Investing Activities | - | - | - | 9.68 Million | 0.44 | 1.00 |
| Financing Cash Flow | 388.86 Million | 57.68 Million | -209.79 Thousand | 66.1 Million | 67.85 Million | 176.4 Million |
| Debt repayment | -85 Million | -57.86 Million | - | -66.6 Million | -68.13 Million | -498 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -77.92 Thousand | -121.21 Thousand | -44.29 Thousand | - |
| Common Stock Issuance | 304.47 Million | - | - | - | - | 176.75 Million |
| Other Financing Activities | -605 Thousand | -185.85 Thousand | -131.86 Thousand | 132.83 Million | -243.25 Thousand | -343.63 Thousand |
| Accounts receivables | - | - | - | 7.25 Million | - | 12.25 Million |
| Accounts payables | - | - | - | -9.63 Million | - | 19.83 Million |
| Inventory | - | - | - | - | - | 1.00 |
| Other working capital | - | - | - | 378.95 Thousand | - | 2.74 Million |
| Cash at beginning of period | 109.47 Million | 72.9 Million | 137.27 Million | 160.09 Million | 160.09 Million | 59.63 Million |
| Cash at end of period | 258.91 Million | 67.79 Million | 72.9 Million | 72.9 Million | 137.27 Million | 160.09 Million |
| Capital Expenditure | -216.02 Million | -58.03 Million | -61.44 Million | -152.9 Million | -93.56 Million | -98.47 Million |
| Effect of forex changes on cash | - | 1.61 Million | -3.1 Million | -5.57 Million | -2 Million | -4.82 Million |
| Net cash flow / Change in cash | 149.44 Million | -5.1 Million | -64.36 Million | -87.19 Million | -22.82 Million | 100.46 Million |
| Free Cash Flow | -216.02 Million | -64.4 Million | -67.27 Million | -154.17 Million | -88.91 Million | -71.14 Million |
INFT
MYSORPETRO
SFG
PSH-R
LHGI
WLFFF